Advertisement

Colgate-Palmolive Stock Acts Like Young Growth Company

Colgate-Palmolive Stock Acts Like Young Growth Company

Staid home products giant Colgate-Palmolive, with roughly $20 billion annual sales, is acting more like a young growth stock. It's no surprise the Colgate-Palmolive stock Relative Strength (RS) Rating climbed to 81 Wednesday, up from 78. The upgraded 81 RS Rating indicates that Colgate-Palmolive stock outperformed 81% of all stocks in IBD's database over the past year.